Jeffery A Walker

US Patent:

20120143805, Jun 7, 2012

Filed:

Mar 5, 2010

Appl. No.:

13/390648

Inventors:

Larry Gold - Boulder CO, US
Edward N. Brody - Boulder CO, US
Rachel M. Ostroff - Westminster CO, US
Dominic Zichi - Boulder CO, US
Alex A.E. Stewart - Waltham MA, US
Michael Riel-Mehan - Louisville CO, US
Mark Messenbaugh - Lakewood CO, US
Randee S. Schwartz - Broomfield CO, US
Jeffery Walker - Boulder CO, US
Stephen Alaric Williams - Boulder CO, US
Malti Nikrad - Boulder CO, US

Assignee:

SOMALOGIC, INC. - Boulder CO

International Classification:

G06N 5/00
C40B 30/04

US Classification:

706 20, 506 9

Abstract:

The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of cancer. In one aspect, the disclosure provides biomarkers that can be used alone or in various combinations to diagnose cancer. In another aspect, methods are provided for diagnosing cancer in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 47, wherein the individual is classified as having cancer, or the likelihood of the individual having cancer is determined, based on the at least one biomarker value.

US Patent:

20120165217, Jun 28, 2012

Filed:

Apr 3, 2010

Appl. No.:

13/391794

Inventors:

Larry Gold - Boulder CO, US
Edward N. Brody - Boulder CO, US
Rachel M. Ostroff - Westminster CO, US
Dominic Zichi - Boulder CO, US
Alex A.E. Stewart - Waltham MA, US
Michael Riel-Mehan - Louisville CO, US
Mark Messenbaugh - Lakewood CO, US
Randee S. Schwartz - Broomfield CO, US
Jeffery Walker - Boulder CO, US
Stephen Alaric Williams - Boulder CO, US
Malti Nikrad - Boulder CO, US

Assignee:

SOMALOGIC, INC. - Boulder CO

International Classification:

C40B 30/04
G06F 19/00

US Classification:

506 9, 702 19

Abstract:

The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of cancer. In one aspect, the disclosure provides biomarkers that can be used alone or in various combinations to diagnose cancer. In another aspect, methods are provided for diagnosing cancer in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 24, wherein the individual is classified as having cancer, or the likelihood of the individual having cancer is determined, based on the at least one biomarker value.